Log In Sign up
The largest database of trusted experimental protocols

Lamp2 alexafluor 488 h4b4

Manufactured by Thermo Fisher Scientific
Visit Supplier
Sourced in Germany

LAMP2-AlexaFluor 488 (H4B4) is a fluorescently labeled antibody that targets the LAMP2 protein. It is designed for use in immunofluorescence applications to detect and visualize the cellular localization of LAMP2.

Automatically generated - may contain errors

Lab products found in correlation

Rab27a, by Abcam (2 mentions) Ci mpr 2g11, by Abcam (2 mentions) Eea 1 14 eea1, by BD (2 mentions) Perforin pf 344, by Mabtech (2 mentions) Nkg2d 1d11, by BioLegend (2 mentions)

Spelling variants of this product

LAMP2 (12 citations)

2 protocols using lamp2 alexafluor 488 h4b4

1

Multiplex Imaging of Cytotoxic Granule Components

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following Abs were used against perforin (dG9), LAMP1-AlexaFluor 488 (H4A3), CD3 (UCHT1), CD56 (HCD56), NKG2D (1D11) (BioLegend); CI-MPR (2G11), dynein heavy chain, Rab27a (Abcam); EEA-1 (14/EEA1; BD Biosciences); cathepsin D, Rab7, Rab9 (Cell Signaling); LAMP1 (H4A3), LAMP2 (H4B4), granzyme B (GB7), Munc13-4, Rab14 (D-5) (Santa Cruz Biotechnology); myosin IIA, actin (AC-15) (Sigma), VAMP7 (Synaptic Systems); LAMP2-AlexaFluor 488 (H4B4) (eBiosciences); perforin (Pf-344, for immunoblotting; Mabtech).
Gil-Krzewska A., Saeed M.B., Oszmiana A., Fischer E.R., Lagrue K., Gahl W.A., Introne W.J., Coligan J.E., Davis D.M, & Krzewski K. (2018). An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome. The Journal of Allergy and Clinical Immunology, 142(3), 914-927.e6.
+ Open protocol
+ Expand
2

Cytotoxic Granule Trafficking Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used against perforin (dG9), lysosome-associated membrane protein (LAMP) 1–Alexa Fluor 488 (H4A3), CD3 (UCHT1), CD56 (HCD56), and NKG2D (1D11; BioLegend, San Diego, Calif); cation-independent mannose 6-phosphate receptor (CI-MPR; 2G11), dynein heavy chain, and Ras-associated binding protein (Rab) 27a (Abcam, Cambridge, United Kingdom); early endosome antigen 1 ([EEA-1] 14/EEA1; BD Biosciences, San Jose, Calif); cathepsin D, Rab7, and Rab9 (Cell Signaling, Danvers, Mass); LAMP1 (H4A3), LAMP2 (H4B4), granzyme B (GB7), Munc13-4, and Rab14 (D-5; Santa Cruz Biotechnology, Dallas, Tex); myosin IIA and actin (AC-15; Sigma, St Louis, Mo); vesicle associated membrane protein 7 (Synaptic Systems, Goettingen, Germany); LAMP2–Alexa Fluor 488 (H4B4) (eBioscience, San Diego, Calif); and perforin (Pf-344, for immunoblotting; Mabtech, Stockholm, Sweden).
Gil-Krzewska A., Saeed M.B., Oszmiana A., Fischer E.R., Lagrue K., Gahl W.A., Introne W.J., Coligan J.E., Davis D.M, & Krzewski K. (2018). An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome. The Journal of Allergy and Clinical Immunology, 142(3), 914-927.e6.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!